Loading...
Alloantibodies in von Willebrand disease
The development of alloantibodies against von Willebrand factor (VWF) represents a rare but serious complication of treatment of von Willebrand disease (VWD), occurring in ∼5% to 10% of type 3 VWD patients. Affected patients can present with a range of symptoms, including lack or loss of hemostatic...
Na minha lista:
Main Authors: | , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
American Society of Hematology
2013
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3731926/ https://ncbi.nlm.nih.gov/pubmed/23297130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-10-462085 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|